Importance of the Assessment Time Window for Intravenous Tranexamic Acid and Thromboembolic Events-Reply

JAMA Surg. 2022 Jan 1;157(1):80-81. doi: 10.1001/jamasurg.2021.4141.

Authors

Isabel Taeuber¹, Suma Choorapoikayil¹, Patrick Meybohm²

Affiliations

¹ Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt am Main, Germany.
² Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Wuerzburg, Wuerzburg, Germany.

PMID: 34468712
DOI: 10.1001/jamasurg.2021.4141

No abstract available

Publication types

Comment

MeSH terms

Antifibrinolytic Agents*
Humans
Thromboembolism*
Tranexamic Acid*

Substances

Antifibrinolytic Agents
Tranexamic Acid